- letzte 200 News
- Archiv
| Zeit | Aktuelle Nachrichten | Rating | Leser | ||
|---|---|---|---|---|---|
| Fr | Coro Energy - Cost reductions result in board restructuring | 84 | Coro Energy has announced that in light of the unprecedented market changes, its board has initiated a material cost-reduction programme. As a result, James Menzies, the company's CEO, saw his employment... ► Artikel lesen | ||
| Fr | Wheaton Precious Metals - Swings and roundabouts | 152 | On 1 April, Wheaton Precious Metals (WPM) announced that all of its partners' mines are operational, with the exception of Voisey's Bay, Constancia, Yauliyacu and Penasquito. Voisey's Bay is not scheduled... ► Artikel lesen | ||
| Fr | Epwin Group - Responding to COVID-19 | 112 | The coronavirus outbreak has led to widespread temporary closures across the UK building materials supply chain and Epwin has taken similar steps. We have brought our FY19 estimates in line with management's... ► Artikel lesen | ||
| Fr | XP Power - Healthcare customers boost Q1 book-to-bill | 125 | XP Power's Q1 trading update confirmed that revenues increased 4% yoy/qoq and the Chinese facility has returned to normal staffing levels. Strong demand, mainly from healthcare customers, saw a 25%... ► Artikel lesen | ||
| Fr | Numis Corporation - Sound H120 and opportunity post Covid 19 | 120 | Numis expects to report H120 revenues c 10% higher than in H119 with revenue from investment banking slightly down and equities ahead on the back of increased market volatility. Given the impact of... ► Artikel lesen | ||
| Do | BioPorto Diagnostics - BioPorto to collaborate on COVID-19 test | 138 | BioPorto has announced a collaboration with the University of Southern Denmark (SDU) to develop a point-of-care (PoC) test for the detection of COVID-19. The test would employ the company's existing... ► Artikel lesen | ||
| Do | BioLargo - A record-setting year | 116 | BioLargo reported record revenue of $1.86m for 2019, a 36% increase over 2018 and a record single quarter revenue of over $560,000 for Q4. Odor-no-More (ONM) had its best year to date with $1.46m in... ► Artikel lesen | ||
| Do | Norcros - FY20 outturn affected by COVID-19 | 133 | The developing coronavirus pandemic has affected year-end trading for Norcros, with an indicated c £4m impact on EBIT. Operational shutdowns mirroring those of its customers have been undertaken and... ► Artikel lesen | ||
| Do | Helma Eigenheimbau - Macro uncertainty after strong FY19 | 179 | Helma Eigenheimbau closed FY19 with improved revenues and new order intake, coupled with a lower cost of materials and third-party services ratio. It maintains a satisfactory equity ratio of 28.6%,... ► Artikel lesen | ||
| Do | Expert System - Focused on international growth | 128 | Expert generated sales growth of 10% in FY19, slightly below guidance, and reported EBITDA at the midpoint of guidance. The company made good progress in shifting to subscription licensing (76% of licences... ► Artikel lesen | ||
| Mi | Hellenic Petroleum - A flexible refiner in a turbulent time | 105 | Hellenic Petroleum (ELPE) saw a weaker than anticipated Q419 due to the lowest system benchmark margins since Q313. In addition, the Elefsina scheduled turnaround resulted in lower utilisation and sales... ► Artikel lesen | ||
| Mi | The Mission Group - On message | 111 | The Mission has reported FY19 results in line with levels indicated in the year-end update, with an 11% uplift in adjusted PBT and a 5% increase in diluted EPS. The new financial year started well,... ► Artikel lesen | ||
| Di | Esker - Moderating growth expectations for FY20 | 149 | Esker reported FY19 revenue growth of 20%; higher than expected investment in headcount limited the increase in normalised EBIT to 7% yoy. High recurring revenues (80%) and strong order intake in FY19... ► Artikel lesen | ||
| Di | Kazia Therapeutics - Paxalisib trial still on track for H220 start | 121 | In the current viral pandemic, it is worth recalling that brain cancers will arise during and after the epidemic. The core business case for Kazia remains strong as it is developing the only brain penetrating... ► Artikel lesen | ||
| Di | Egdon Resources - Management estimates commercial upside | 125 | Egdon Resources has provided an update on its Biscathorpe project (45% interest) in Lincolnshire. The company has integrated reprocessed 3D seismic data with data from the 2019 Biscathorpe-2 well and... ► Artikel lesen | ||
| Mo | PDL BioPharma - Accelerating asset monetization | 97 | PDL BioPharma announced that the company is targeting either a complete sale or the monetization of its four key assets by the end of 2020, much faster than the two to three years previously communicated.... ► Artikel lesen | ||
| Mo | Quadrise Fuels International - Business development intensifying | 113 | Quadrise's business development activity has intensified in the last nine months, with progress on opportunities in Morocco, South America, Saudi Arabia (KSA) and the marine sector. COVID-19 will potentially... ► Artikel lesen | ||
| 27.03. | Carbios - Key developments and partnerships expected | 192 | We expect further progress from Carbios in 2020, with the start of construction of its PET demonstration plant and the commercial launch of Evanesto by Carbiolice. Following the FY19 rights issue, raising... ► Artikel lesen | ||
| 27.03. | Avon Rubber - Further backlog development | 158 | The latest body armour contract for the US Defense Logistics Agency is for up to $333m, to be delivered over 3.5 years for a legacy product. Avon had identified it as an incremental value-creating opportunity... ► Artikel lesen | ||
| 27.03. | TXT e-solutions - Well-funded to ride out the crisis | 141 | TXT e-solutions reported exceptional growth in 2019, with organic growth of 24% and normalised EBIT growth of 90%. Recent acquisitions have put the Fintech division in a stronger position and the company... ► Artikel lesen | ||
| 26.03. | Applied Graphene Materials - First commercial successes | 161 | In October 2019 Applied Graphene's (AGM's) management announced it was re-aligning resources around dispersion and application technology to better support product development with customers presenting... ► Artikel lesen | ||
| 26.03. | Boku - Outlook maintained for FY20; upside possible | 144 | Boku reported FY19 results that were largely in line with its January trading update. The Payments division doubled adjusted EBITDA in FY19 highlighting the scale benefits of this business, while the... ► Artikel lesen | ||
| 26.03. | Pixium Vision - Strategy in place to mitigate COVID-19 effects | 182 | Pixium recently made prudent operational changes to contain expenditures while keeping the long-term investment thesis intact during the COVID-19 pandemic. With the feasibility studies paused and the... ► Artikel lesen | ||
| 26.03. | Canacol Energy - Fixed-contract gas prices protect cash flows | 172 | Canacol Energy has recently reported record annual production of 143mmscfd for FY19 in line with our estimates. Key drivers for an increase of 28% in production versus FY18 include the completion of... ► Artikel lesen | ||
| 26.03. | Sunesis Pharmaceuticals - 400mg data similar to previous cohort | 116 | On 18 March, Sunesis released the first assessments of the 400mg cohort in its ongoing dosing study of vecabrutinib for B-cell malignancies. Two (of three) patients in this cohort showed stable disease... ► Artikel lesen |
Sie erhalten auf FinanzNachrichten.de kostenlose Realtime-Aktienkurse von und
